The global market for Livestock Diagnosis was valued at US$6.0 Billion in 2024 and is projected to reach US$9.3 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Livestock Diagnosis market.
As global meat, dairy, and egg production continues to grow, especially in Asia-Pacific, Africa, and Latin America, disease surveillance and herd health monitoring are becoming critical to sustainable livestock farming. Increasing concerns over antimicrobial resistance (AMR), foodborne illnesses, and pandemic risks are further elevating the need for routine diagnostics, especially in densely populated or industrial-scale farms. These factors are positioning livestock diagnostics not merely as a veterinary tool but as an integral component of food security and public health infrastructure.
Wearable sensors and precision livestock monitoring platforms are enabling continuous health surveillance based on behavioral, physiological, and biometric data. Combined with AI and machine learning algorithms, these systems detect subtle deviations in feeding, temperature, or movement - serving as early indicators of disease or stress. Remote diagnostics and tele-veterinary services are also gaining traction, particularly in remote or underserved farming regions. These innovations are laying the groundwork for precision livestock health management, where disease control becomes proactive rather than reactive.
Moreover, rising consumer demand for antibiotic-free and hormone-free animal products is compelling producers to invest in disease detection as a means to minimize prophylactic drug use. The growth of traceability standards and sustainable certifications in meat and dairy supply chains is further encouraging systematic diagnostic testing. As animal health becomes a defining factor in brand differentiation and market access, livestock diagnostics are becoming a strategic priority for both producers and agribusiness companies.
Technological progress in molecular biology, biosensors, and real-time data analytics is making diagnostics more accessible, affordable, and deployable across diverse farm settings. Governments and multinational agencies are funding veterinary infrastructure upgrades to improve outbreak preparedness and food safety. Additionally, livestock producers are recognizing that early diagnosis translates into lower treatment costs, reduced losses, and improved reproductive efficiency. These dynamics are fostering a strong growth trajectory for livestock diagnostics as a critical enabler of sustainable and resilient animal agriculture worldwide.
Segments: Product (Consumables, Systems, Software, Other Products); Technology (Immunodiagnostics, Molecular Diagnostics, Other Technologies); Animal Type (Ruminants, Swine, Poultry, Other Animal Types); End-Use (Reference Laboratories, Diagnostic Hospitals & Clinics, Point-Of-Care Testing, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Livestock Diagnosis Market - Key Trends & Drivers Summarized
Why Is Livestock Diagnosis Central to Modern Veterinary and Agricultural Management?
Livestock diagnosis refers to the detection, monitoring, and management of diseases and physiological conditions in farm animals, including cattle, poultry, swine, sheep, and goats. With livestock health directly impacting food safety, productivity, and economic output, rapid and accurate diagnosis has become a top priority in global animal husbandry. Diagnostic tools help identify infections, reproductive conditions, metabolic disorders, and zoonotic diseases - facilitating early intervention, treatment optimization, and prevention of outbreaks that could devastate herds or enter the human food chain.As global meat, dairy, and egg production continues to grow, especially in Asia-Pacific, Africa, and Latin America, disease surveillance and herd health monitoring are becoming critical to sustainable livestock farming. Increasing concerns over antimicrobial resistance (AMR), foodborne illnesses, and pandemic risks are further elevating the need for routine diagnostics, especially in densely populated or industrial-scale farms. These factors are positioning livestock diagnostics not merely as a veterinary tool but as an integral component of food security and public health infrastructure.
How Are Diagnostic Technologies Evolving to Support Precision Livestock Farming?
Advancements in point-of-care diagnostics, biosensors, and molecular detection are revolutionizing how livestock diseases are identified and managed. Portable PCR devices, rapid immunoassays, ELISA kits, and microfluidic lab-on-chip systems are enabling on-site diagnosis of viral, bacterial, and parasitic infections in minutes rather than days. These tools are increasingly integrated into mobile veterinary units and farm management systems, allowing for faster decision-making and targeted treatments.Wearable sensors and precision livestock monitoring platforms are enabling continuous health surveillance based on behavioral, physiological, and biometric data. Combined with AI and machine learning algorithms, these systems detect subtle deviations in feeding, temperature, or movement - serving as early indicators of disease or stress. Remote diagnostics and tele-veterinary services are also gaining traction, particularly in remote or underserved farming regions. These innovations are laying the groundwork for precision livestock health management, where disease control becomes proactive rather than reactive.
What Trends Are Influencing Adoption Across Animal Health Ecosystems?
The intensification of animal farming and increasing biosecurity regulations are driving widespread adoption of livestock diagnostics across both developed and emerging markets. Large-scale dairy and poultry operations are implementing herd-wide diagnostic programs to manage production efficiency and reduce the economic impact of disease. Government initiatives, including animal health surveillance programs, livestock insurance, and disease eradication campaigns, are promoting the use of diagnostic tests at both the individual and population level.Moreover, rising consumer demand for antibiotic-free and hormone-free animal products is compelling producers to invest in disease detection as a means to minimize prophylactic drug use. The growth of traceability standards and sustainable certifications in meat and dairy supply chains is further encouraging systematic diagnostic testing. As animal health becomes a defining factor in brand differentiation and market access, livestock diagnostics are becoming a strategic priority for both producers and agribusiness companies.
What Is Driving Growth in the Global Livestock Diagnosis Market?
The growth in the livestock diagnosis market is driven by rising concerns over animal disease outbreaks, increasing demand for safe animal-derived products, and the global shift toward precision farming practices. A primary driver is the rising prevalence of transboundary animal diseases - such as avian influenza, foot-and-mouth disease, and African swine fever - which are prompting stricter surveillance and rapid-response diagnostics at the farm and national levels.Technological progress in molecular biology, biosensors, and real-time data analytics is making diagnostics more accessible, affordable, and deployable across diverse farm settings. Governments and multinational agencies are funding veterinary infrastructure upgrades to improve outbreak preparedness and food safety. Additionally, livestock producers are recognizing that early diagnosis translates into lower treatment costs, reduced losses, and improved reproductive efficiency. These dynamics are fostering a strong growth trajectory for livestock diagnostics as a critical enabler of sustainable and resilient animal agriculture worldwide.
Report Scope
The report analyzes the Livestock Diagnosis market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Product (Consumables, Systems, Software, Other Products); Technology (Immunodiagnostics, Molecular Diagnostics, Other Technologies); Animal Type (Ruminants, Swine, Poultry, Other Animal Types); End-Use (Reference Laboratories, Diagnostic Hospitals & Clinics, Point-Of-Care Testing, Other End-Uses).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Livestock Diagnosis Consumables segment, which is expected to reach US$4.3 Billion by 2030 with a CAGR of a 8.8%. The Livestock Diagnosis Systems segment is also set to grow at 8.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.6 Billion in 2024, and China, forecasted to grow at an impressive 12.2% CAGR to reach $2.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Livestock Diagnosis Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Livestock Diagnosis Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Livestock Diagnosis Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abaxis Inc., Advanced Animal Diagnostics, Alfa Wassermann, Antech Diagnostics, AsureQuality Limited and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 34 companies featured in this Livestock Diagnosis market report include:
- Abaxis Inc.
- Advanced Animal Diagnostics
- Alfa Wassermann
- Antech Diagnostics
- AsureQuality Limited
- bioMérieux S.A.
- Bio-Rad Laboratories Inc.
- Covetrus Inc.
- Diagnostics For Animals (D4A)
- DiaSys Diagnostic Systems GmbH
- Elanco Animal Health Inc.
- Eurolyser Diagnostica GmbH
- Heska Corporation
- IDEXX Laboratories Inc.
- Merck Animal Health
- Neogen Corporation
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Zoetis Inc.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What's Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abaxis Inc.
- Advanced Animal Diagnostics
- Alfa Wassermann
- Antech Diagnostics
- AsureQuality Limited
- bioMérieux S.A.
- Bio-Rad Laboratories Inc.
- Covetrus Inc.
- Diagnostics For Animals (D4A)
- DiaSys Diagnostic Systems GmbH
- Elanco Animal Health Inc.
- Eurolyser Diagnostica GmbH
- Heska Corporation
- IDEXX Laboratories Inc.
- Merck Animal Health
- Neogen Corporation
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Zoetis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 472 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 6 Billion |
| Forecasted Market Value ( USD | $ 9.3 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
